Assertio Therapeutics
ASRT
#9671
Rank
A$86.65 M
Marketcap
A$13.50
Share price
-5.04%
Change (1 day)
855.30%
Change (1 year)

Earnings for Assertio Therapeutics (ASRT)

Earnings in 2025 (TTM): -A$42.06 Million

According to Assertio Therapeutics 's latest financial reports the company's current earnings are A$0.13 Billion. In 2024 the company made an earning of -A$28.25 Million, an increase over its 2023 earnings that were of -A$0.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Assertio Therapeutics from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$42.06 Million48.89%
2024 -A$28.25 Million-92.46%
2023 -A$0.38 Billion-744.93%
2022 A$58.1 M304.52%
2021 A$14.36 M-132.53%
2020 -A$44.15 Million-81.97%
2019 -A$0.25 Billion-253.57%
2018 A$0.15 B-451.81%
2017 -A$45.33 Million-258.05%
2016 A$28.67 M-138.59%
2015 -A$74.32 Million-121.01%
2014 A$0.35 B2275.01%
2013 A$14.89 M-133.45%
2012 -A$44.52 Million-141.87%
2011 A$0.10 B1496.17%
2010 A$6.66 M-121.23%
2009 -A$31.37 Million22.98%
2008 -A$25.51 Million-135.96%
2007 A$70.93 M
2003 -A$43.87 Million
2000 -A$11.55 Million43.5%
1999 -A$8.05 Million58.6%
1998 -A$5.08 Million580%
1997 -A$0.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-A$27.1 Million-31.08%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-A$0.24 Billion 505.39%๐Ÿ‡บ๐Ÿ‡ธ USA